England's health insurance has covered only 18 'unlicensed' cannabis prescriptions

Since a new law took effect a year ago, England's National Health Service (NHS) has reimbursed patients on only 18 occasions for "unlicensed" cannabis-based products that have not undergone clinical trials, according to government data. The data - which covers November 2018 through August 2019 - relates only to prescriptions in England. Health-care authorities in England, Scotland, Wales and Northern Ireland operate independently. In the United Kingdom, only Epidiolex, nabilone and Sativex are...